Recently, the lowest average wholesale price of 200 milligram Celebrex and the price of multiple strengths of Abilify dropped dramatically, resulting in major cost savings to Medicare set-aside allocations.
A widely used, non-steroidal anti-inflammatory drug, Celebrex (Celecoxib), is FDA-approved for several conditions:
Per Red Book, the lowest average wholesale price for 200 milligram Celecoxib dropped from $1.79 to $0.33, an 81.56% reduction.
Abilify (Aripiprazole) is an antipsychotic drug FDA-approved for the following conditions:
Per Red Book, the lowest average wholesale price for multiple strengths (2 milligrams to 30 milligrams) of Aripiprazole dropped from the $30 to $36 range to a range of $0.07 to $0.17 per dose, an almost 100% price reduction.
Because Tower’s system tracks all medications allocated in MSA reports, we have already pulled reports from the past two years that allocated these medications and advised clients of the potential for a reduction. You can also contact us to determine whether a particular MSA qualifies for a reduction. Revisions to the MSA can be done now or prior to MSA submission to the Centers for Medicare and Medicaid.
Dan Anders is chief compliance officer at Tower MSA Partners LLC. This entry is republished with permission from the Tower MSP Compliance Blog.
Mar 11, 2021
CWCI is pleased to announce that registration is now open for our 57th Annual Meeting, which will …
Mar 16, 2021
Overview: The Shoulder is the 2nd most often injured body part for injured workers. There are a va …
Mar 18-20, 2021
WILG® has put together a two-day event to educate workers’ compensation claimants’ attorneys on le …